SCHEMBL14214637

SCHEMBL14214637

CCC(C)(C)c1ccc2cccnc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
HTT P42858 1/20 0.47
NR4A2 P43354 1/20 0.47
TRPV1 Q8NER1 4/20 0.42
CYP3A4 P08684 3/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP3 P42574 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10285521 0.87 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ACASP1CYP1A2
SCHEMBL26033494 0.83 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL420840 0.82 ALDH1A1 (0.58) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL18463936 0.79 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL28268758 0.79 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL14269044 0.79 SMN1; SMN2 (0.42) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL20747972 0.78 AHR (0.43) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL19203546 0.77 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ACASP1CASP7
SCHEMBL12524759 0.77 OGA (0.38) ALDH1A1NPC1RAB9ALMNAMAPK1
SCHEMBL27771689 0.77 ALDH1A1 (0.51) ALDH1A1MEN1KMT2ACASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080124384-A1 Heteroaryl Substituted Piperazinyl-Pyridine Analogues NEUROGEN CORPORATION 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124384-A1 Heteroaryl Substituted Piperazinyl-Pyridine Analogues PIGO, GPR52, GPR88 ALDH1A1 1028/4885MEN1 4697/4885KMT2A 3488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.